To Study the Role of Plasma Von Willebrand Factor Antigen (vWF) to A Disintegrin-like and Metalloproteinase With Thrombospondin Type-1 Motifs 13 (ADAMTS-13) Activity Ratio as a Predictor of Development of Extrahepatic Organ Failure in Acute on Chronic Liver Failure (ACLF) Patients.
Clinical trial NCT06066814 · UNKNOWN
Trial details
- NCT number
- NCT06066814
- Sponsor
- Institute of Liver and Biliary Sciences, India
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-10-07
- Primary completion
- 2023-12-31
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.